Yunnan Baiyao Earnings Quality Analysis
Journal of Business and Marketing · 2024
DOI: 10.62517/jbm.202409203 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Business and Marketing, 2024. Verfasst von Jing Li und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The “14th Five-Year Plan" for the development of traditional Chinese medicine clearly states that "We should promote the development of traditional Chinese medicine inheritance and innovation". Under the favorable policy, the Chinese medicine industry has ushered in valuable development opportunities. However, some Chinese medicine enterprises have insufficient innovation ability, and the competition in the industry has been intensifying, and the quality of their profitability is of great concern. This paper takes Yunnan Baiyao as an example, and analyses its earnings quality from five dimensions: profitability, truthfulness, cash-change ability, growth and sustainability. Finally, we analyze the problems of Yunnan Baiyao's earnings quality problems and puts forward corresponding measures to solve them, in order to provide certain reference for the Chinese medicine industry to improve profitability quality.
Zitieren
APA
Li, J., & Liu, S. (2024). Yunnan Baiyao Earnings Quality Analysis. Journal of Business and Marketing. https://doi.org/10.62517/jbm.202409203
Vancouver
Li J, Liu S. Yunnan Baiyao Earnings Quality Analysis. Journal of Business and Marketing. 2024. doi:10.62517/jbm.202409203
BibTeX
@article{Li2024,
author = {Li, Jing and Liu, Shuo},
title = {Yunnan Baiyao Earnings Quality Analysis},
journal = {Journal of Business and Marketing},
year = {2024},
doi = {10.62517/jbm.202409203}
}
EUVIMED